Polymyalgia rheumatica is a musculoskeletal disorder that causes aching and stiffness in the upper arms, neck, lower back and thighs and can be difficult for clinicians to confidently pinpoint since its symptoms occur in many other rheumatic diseases.
The boost in efficiency for measuring such scarring could make it easier for clinicians to overcome the time-consuming process of quantifying late gadolinium enhancement (LGE)—a proven predictor of hypertrophic cardiomyopathy.
“Although this study evaluates a small subset of astronauts, it's significantly larger than any previously published study of its kind involving astronauts or Russian cosmonauts," study author Donna R. Roberts said.
The researchers analyzed 39 consecutive patients with 44 pathologically confirmed cirrhotic nodules who first received a CEUS exam, followed by a traditional follow-up ultrasound every three or four months for their study.
“This technology has incredible potential to improve care, whether it is by better training doctors to perform procedures or helping patients know what to expect when they arrive at the hospital,” Ziv Haskal, creator of the technology said.